We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SLVM:NYSESylvamo Corporation Analysis

Data as of 2026-09-04 - not real-time

$35.93

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

At $35.92, Sylvamo Corporation shows a bearish moving-average alignment, with shorter averages beneath longer ones. Across the trailing 30 sessions it lost 6.1%. RSI sits at 43.3, which reads as neutral, and MACD momentum is bearish. The recent range runs from support at $34.25 up to resistance at $41.10.
Valuation screens as undervalued, on a P/E of 19.2 with no clean sector comparison available. Sell-side targets cluster 42.7% above the current quote.
Risk comes out at 7 of a possible 10, a elevated reading. With 30-day volatility of 41.1%, a beta of 0.69 and a maximum drawdown of 36.9%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
Timeframes disagree: the short-term read is sell while the long-term read is hold, conviction 1 out of 10.

Top Market Events

Sylvamo Corporation NYSE:SLVM reported weaker-than-expected second-quarter earnings on Friday, with both profit and...MEMPHIS, Tenn., August 07, 2026--Sylvamo NYSE: SLVM , the world’s paper company, is releasing second quarter...Sylvamo SLVM delivered earnings and revenue surprises of +121.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 4/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 43.00
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 3/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 43.00
  • Analyst targets imply +42.7% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • Analyst targets imply +42.7% versus the current price
  • Negative free cash flow
  • P/E ratio of 19.2

Key Metrics & Analysis

Financial Health

Revenue Growth1.50%
Profit Margin2.31%
P/E Ratio19.2
ROE7.94%
ROA4.33%
Debt/Equity107.96
P/B Ratio1.5
Op. Cash Flow$209.0M
Free Cash Flow$-16375000

Technical Analysis

TrendBearish
RSI43.3
Support$34.25
Resistance$41.10
MA 20$37.05
MA 50$37.82
MA 200$43.00
MACDBearish
VolumeDecreasing
Fear & Greed Index96.27

Valuation

Fair Value$26.73
Target Price$51.25
Upside/Downside42.66%
GradeUndervalued
TypeBlend

Risk Assessment

Beta0.69
Volatility41.11%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.